An Observational Study Called FIRST-2.0 to Learn More About the Use of the Study Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions

Clinical trial NCT05703880 · COMPLETED

Trial details

NCT number: NCT05703880
Sponsor: Bayer
Status: COMPLETED
Study type: OBSERVATIONAL

Chronic Kidney Disease Type 2 Diabetes Mellitus

Start date: 2023-06-01
Primary completion: 2024-10-01
Enrollment: 15948

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.